Article
Antigen-scaffolds drive preferential expansion of functional genetically engineered CAR and TCR T cells
2025-11-03
Abstract excerpt
<h4>Summary</h4> The engineering of autologous T cells to express chimeric antigen receptors (CARs) can induce profound clinical responses in haematological malignancies, while T cell receptor-engineered T (TCR T) cells have led to durable responses in clinical trials for solid tumours. However, clinical manufacturing of engineered T cells is resource-intensive and often yields highly differentiated, exhausted ef...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b58f4304-731c-525e-9713-e72ad799cb67
- DOI
- 10.1101/2025.11.01.686037
